Skip to search formSkip to main contentSkip to account menu

Vaccinia Prostate Specific Antigen Vaccine

Known as: Prostate Specific Antigen Expressing Vaccinia Virus Vaccine, VPSA, rV-PSA Vaccine 
A vaccine consisting of recombinant vaccinia virus encoding prostate specific antigen (PSA). Vaccination with recombinant vaccinia prostate-specific… 
National Institutes of Health

Related topics

Related topics

11 relations
Cytotoxic T-LymphocytesGene Expression RegulationNCIt Antineoplastic Agent TerminologyProstate-Specific Antigen

Narrower (1)

PROSTVAC

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory
A prime-boost HCV vaccine strategy induces durable and broad T cell responses, characteristic of those associated with viral… 
Highly Cited
2006
Highly Cited
2006
Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16.
BACKGROUND The identification of surrogate endpoints that can replace true outcome endpoints is crucial to the rapid evaluation… 
Highly Cited
2004
Highly Cited
2004
Nonmethylated CG Motifs Packaged into Virus-Like Particles Induce Protective Cytotoxic T Cell Responses in the Absence of Systemic Side Effects
DNA rich in nonmethylated CG motifs (CpGs) greatly facilitates induction of immune responses against coadministered Ags. CpGs are… 
Highly Cited
1993
Highly Cited
1993
Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV
Hepatitis C virus (HCV) is a major cause of posttransfusion and community-acquired hepatitis, and a majority of individuals… 
Highly Cited
1992
Highly Cited
1992
Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G.
To investigate the contribution of immunity to individual respiratory syncytial (RS) virus proteins to the augmentation of… 
Highly Cited
1990
Highly Cited
1990
Transient dominant selection of recombinant vaccinia viruses
A general method for constructing and selecting recombinant vaccinia viruses with insertions, deletions, or mutations in any gene… 
Highly Cited
1989
Highly Cited
1989
Identification of the fusion peptide of primate immunodeficiency viruses.
Membrane fusion induced by the envelope glycoproteins of human and simian immunodeficiency viruses (HIV and SIVmac) is a… 
Highly Cited
1988
Highly Cited
1988
Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses
CTL are held to be an important host defense mechanism in persistent herpes-virus infections. We have therefore studied the… 
Highly Cited
1986
Highly Cited
1986
Differences in antigen presentation to MHC class I-and class II- restricted influenza virus-specific cytolytic T lymphocyte clones
We have examined requirements for antigen presentation to a panel of MHC class I-and class II-restricted, influenza virus… 
Highly Cited
1984
Highly Cited
1984
Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus…
Potential live vaccines using recombinant vaccinia viruses have been constructed for both hepatitis B and herpes simplex. These… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)